The TP53-ARF tumor suppressor pathway is frequently disrupted in large/cell anaplastic medulloblastoma

被引:50
作者
Frank, AJ
Hernan, R
Hollander, A
Lindsey, JC
Lusher, ME
Fuller, CE
Clifford, SC
Gilbertson, RJ
机构
[1] St Jude Childrens Res Hosp, Dept Dev Neurobiol, Memphis, TN 38105 USA
[2] St Jude Childrens Res Hosp, Dept Pathol, Memphis, TN 38105 USA
[3] Univ Newcastle, Sch Med, No Inst Canc Res, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England
来源
MOLECULAR BRAIN RESEARCH | 2004年 / 121卷 / 1-2期
关键词
medulloblastoma; anaplastic; TP53; ARF; INK4A;
D O I
10.1016/j.molbrainres.2003.11.016
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
We analyzed the TP53 and INK4A/ARF loci in 29 pediatric medulloblastomas. Mutually exclusive mutation in TP53, methylation of P14(ARF) or deletion of INK4A/ARF were identified in 21% (6/29) of tumors. Five of these alterations were detected in large cell/anaplastic medulloblastomas or tumors with significant anaplasia. Our data provide the first evidence that alterations within the TP53-ARF tumor suppressor pathway contribute to development of aggressive forms of medulloblastoma. (C) 2004 Elsevier B.V. All rights reserved.
引用
收藏
页码:137 / 140
页数:4
相关论文
共 28 条
[1]   p14ARF links the tumour suppressors RB and p53 [J].
Bates, S ;
Phillips, AC ;
Clark, PA ;
Stott, F ;
Peters, G ;
Ludwig, RL ;
Vousden, KH .
NATURE, 1998, 395 (6698) :124-125
[2]   Molecular cytogenetic analysis of medulloblastomas and supratentorial primitive neuroectodermal tumors by using conventional banding, comparative genomic hybridization, and spectral karyotyping [J].
Bayani, J ;
Zielenska, M ;
Marrano, P ;
Ng, YK ;
Taylor, MD ;
Jay, V ;
Rutka, JT ;
Squire, JA .
JOURNAL OF NEUROSURGERY, 2000, 93 (03) :437-448
[3]   Large cell/anaplastic medulloblastomas: A Pediatric Oncology Group study [J].
Brown, HG ;
Kepner, JL ;
Perlman, EJ ;
Friedman, HS ;
Strother, DR ;
Duffner, PK ;
Kun, LE ;
Goldthwaite, PT ;
Burger, PC .
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY, 2000, 59 (10) :857-865
[4]   The molecular pathology of p53 in primitive neuroectodermal tumours of the central nervous system [J].
Burns, ASYW ;
Jaros, E ;
Cole, M ;
Perry, R ;
Pearson, AJ ;
Lunec, J .
BRITISH JOURNAL OF CANCER, 2002, 86 (07) :1117-1123
[5]   Histopathologic grading of medulloblastomas - A pediatric oncology group study [J].
Eberhart, CG ;
Kepner, JL ;
Goldthwaite, PT ;
Kun, LE ;
Duffner, PK ;
Friedman, HS ;
Strother, DR ;
Burger, PC .
CANCER, 2002, 94 (02) :552-560
[6]   Classifying the medulloblastoma: insights from morphology and molecular genetics [J].
Ellison, D .
NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY, 2002, 28 (04) :257-282
[7]   What's new in neuro-oncology? Recent advances in medulloblastoma [J].
Ellison, DW ;
Clifford, SC ;
Gajjar, A ;
Gilbertson, RJ .
EUROPEAN JOURNAL OF PAEDIATRIC NEUROLOGY, 2003, 7 (02) :53-66
[8]   p53 gene mutation and ink4a-arf deletion appear to be two mutually exclusive events in human glioblastoma [J].
Fulci, G ;
Labuhn, M ;
Maier, D ;
Lachat, Y ;
Hausmann, O ;
Hegi, ME ;
Janzer, RC ;
Merlo, A ;
Van Meir, EG .
ONCOGENE, 2000, 19 (33) :3816-3822
[9]   LARGE-CELL MEDULLOBLASTOMAS - A DISTINCT VARIANT WITH HIGHLY AGGRESSIVE-BEHAVIOR [J].
GIANGASPERO, F ;
RIGOBELLO, L ;
BADIALI, M ;
LODA, M ;
ANDREINI, L ;
BASSO, G ;
ZORZI, F ;
MONTALDI, A .
AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 1992, 16 (07) :687-693
[10]   The role of p53 in determining sensitivity to radiotherapy [J].
Gudkov, AV ;
Komarova, EA .
NATURE REVIEWS CANCER, 2003, 3 (02) :117-129